NASDAQ:FGEN - FibroGen Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$57.72 -0.78 (-1.33 %)
(As of 02/19/2019 10:25 AM ET)
Previous Close$58.50
Today's Range$57.72 - $58.91
52-Week Range$37.27 - $68.55
Volume2,398 shs
Average Volume624,912 shs
Market Capitalization$4.90 billion
P/E Ratio-33.70
Dividend YieldN/A
Beta1.77

Analyst Ratings

FibroGen (NASDAQ:FGEN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for FibroGen in the last 12 months. Their average twelve-month price target is $75.00, suggesting that the stock has a possible upside of 29.94%. The high price target for FGEN is $84.00 and the low price target for FGEN is $71.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.002.672.80
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $75.00$76.3333$76.3333$77.60
Price Target Upside: 29.94% upside93.25% upside54.12% upside23.27% upside

FibroGen (NASDAQ:FGEN) Consensus Price Target History

Price Target History for FibroGen (NASDAQ:FGEN)

FibroGen (NASDAQ:FGEN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/11/2019Stifel NicolausInitiated CoverageBuy ➝ Buy$71.00HighView Rating Details
12/18/2018CitigroupUpgradeNeutral ➝ Buy$71.00MediumView Rating Details
12/17/2018MizuhoReiterated RatingBuy$74.00MediumView Rating Details
10/15/2018Leerink SwannSet Price TargetOutperform ➝ Buy$82.00 ➝ $84.00LowView Rating Details
9/12/2017Jefferies Financial GroupReiterated RatingBuy$75.00LowView Rating Details
8/9/2017William BlairReiterated RatingOutperformMediumView Rating Details
7/21/2017Goldman Sachs GroupDowngradeBuy ➝ Neutral$31.00MediumView Rating Details
(Data available from 2/19/2017 forward)
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel